BSECompany Update5 Oct 2026 · 5 Oct 2026, 04:43 pm

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Genpharmasec Ltd · 531592

✦ AI Summary

Genpharmasec Ltd submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, confirming the dematerialization of securities.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Genpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

d059fd75-b497-4c4f-96db-5cfa0c68caaa.pdf

pdf

Download →
View document text
GENPHARMASEC LIMITED Date: 05.10.2026 BSE Limited The Compliance Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 531592 Subject: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. Dear Sir/Madam, We submit herewith the confirmation certificate received from Satellite Corporate Services Pvt. Ltd, Registrar and Share Transfer Agent (RTA) of the Company as per regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. Kindly take the same on records for your perusal. Thanking you, Yours faithfully, For Genpharmasec Limited Digitally signed by SOHAN SOHAN CHATURVEDI C HATU RVE DI Date: 2026.10.05 16:35:59 +05'30' Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 Encl:- as above 104 & 105, 1st Floor, Gundecha Industrial Premises Co-Operative Soc compliance@genpharmasec.com Ltd., Akurli Road, Kandivali (East), Mumbai 400101. info@genpharmasec.com © +91-86555 50242 iD www.genpharmasec.com CIN : L244231MH1992PLC323914 SATELLITE CORPORATE SERVICES PVT. LTD. Category - I, Registrar to an Issue & Share Transfer Agent, Reg. No. INROOOOOS639 SATELLITE Regd. Off: Office No. A/1D6-107, Dattani Plaza, East West Compound, Andheri Kurla Road, Safed Pool, Sakinaka, Mumbai - 400 O72. Tel: 022-28520461, 022-28520362 E-mail - service@lsatelitecorporate.com, scs pl@lyahoo.co.in GIN NOL: UBSSS0MH1SS4PTC7O05?? Website : www. setelitecorporate.com Date: 05.10.2026 GENPHARMASEC LIMITED OFFICE NO. 104 & 105 1ST FLOOR GUNDECHA INDUSTRIAL PREMISES CO-OP SOC. LTD. AKURLI ROAD KANDIVALI EAST MUMBAI :-400101 Subject: Certificate under Regulation 74(5) of the SEBI (Depository and participants) Regulations, 2018 for the quarter ended 30th September 2026. Dear Sir/Madam, In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026., w.r.t. physical shares certificates received for dematerialization of securities (Equity Shares) of the Company, “GenPharmasec Limited”.We hereby confirm and certify the following: a) The securities comprised in the said certificate(s) have been listed on the Stock Exchanges. b) The said certificate(s) after due verification have been mutilated and cancelled and the name of depository has been substituted in our records as registered owner. However in case of GENPHARMASEC LIMITED no physical certificates are received for demat during the quarter ended 30th September 2026. This is for you information and records. Thanking you, For Satellite Corporate Services Pvt. Ltd. Michael Monteiro (Director)